Paraguay vs Venezuela: Access to anti-retroviral drugs, female (%)
Paraguay
55.0%
in 2024
Venezuela
54.0%
in 2024
Paraguay rank
111th
Venezuela rank
114th
Access to anti-retroviral drugs, female (%) over time
- Paraguay
- Venezuela
How they compare
Paraguay currently reports 55.0% against 54.0% in Venezuela, a difference of 1.0%.
The two have swapped places 3 times across 23 shared years of data; in 2000 it was Venezuela ahead.
Paraguay ranks 111th and Venezuela ranks 114th of 141 countries.
Venezuela has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Paraguay | Venezuela | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 6.1% | 18.0% | 11.9% | Venezuela |
| 2010s | 37.9% | 49.2% | 11.3% | Venezuela |
| 2020s | 51.0% | 53.7% | 2.7% | Venezuela |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Paraguay or Venezuela?
- Paraguay, at 55.0% against 54.0% in Venezuela as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Paraguay and Venezuela?
- 1.0%, with Paraguay ahead.
- How many years of comparable data are there for Paraguay and Venezuela?
- 23 years are reported by both, from 2000 to 2024.
- How do Paraguay and Venezuela rank globally for access to anti-retroviral drugs, female?
- Paraguay ranks 111th and Venezuela ranks 114th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.